Blog Posts by Date: Oct 2020


XIFIN Client and Patient Portals Improve Retention and Accelerate Reimbursements

Typically, if a patient has a question about a bill they receive for laboratory testing, they must call the laboratory to get those questions answered. They also must call the laboratory to request a payment plan, if they cannot afford to pay their entire balance at once. In some cases, patients even need to call the laboratory to pay a balance by...

Read



The Cost of Preserving the Status Quo – It’s Not an All or Nothing Decision Anymore

Whether you’re a laboratory, pathology practice, molecular diagnostic provider, remote patient monitoring organization, or one of the nation’s largest hospitals offering ancillary services, factors causing revenue compression are threatening your bottom line. They include: Testing volume and reimbursement related to COVID-19. With volume...

Read



Automation of Prior Authorizations and Appeals is Possible and Key to Reducing Costs

Many issues are challenging diagnostic providers’ ability to maximize payor reimbursements, such as the significant increase in required prior authorizations (PAs) and the high cost of appeals.These issues are even more difficult for laboratories and remote patient monitoring device companies using traditional billing systems that have few or no...

Read



Digital Pathology Goes Mainstream

Enjoy the following content from our partner, Proscia. COVID-19 has disrupted laboratory medicine in many ways, causing a strong need for new testing, social distancing, and telemedicine.The pandemic has been especially challenging for pathology, which has remained mostly unchanged over the last 150 years. The field has held onto its traditional...

Read



UHC Suspends Prior Auth Requirements for Trichomonas & Candida, Will Adopt CMS Billing Policy for Prostates on January 1, 2021

Suspension of Trichomonas and Candida Prior Auth Requirements Beginning Oct. 1, 2020, for all commercial and UnitedHealthcare Community Plan plans included in the genetic and molecular testing program, UHC will be suspending prior authorization and notification requirements for the following three genetic and molecular CPT codes performed in an...

Read